ObjectiveHealth Company Profile

Background

Overview

ObjectiveHealth is a Nashville-based integrated research and technology platform company specializing in embedding clinical research into physician practices and community health centers. Founded in 2018, the company aims to enhance patient outcomes by providing access to clinical trials at the point of care. By leveraging proprietary AI-driven technology and trained on-site personnel, ObjectiveHealth facilitates the seamless integration of clinical research into routine patient care.

Mission and Vision

ObjectiveHealth's mission is to improve patient outcomes by integrating clinical research into everyday healthcare settings, thereby offering patients access to innovative treatments within their trusted care environments. The company's vision is to transform the clinical research landscape by making trials more accessible and efficient, ultimately accelerating the development of new therapies.

Primary Area of Focus

The company focuses on conducting clinical trials across various therapeutic areas, including gastroenterology, dermatology, urology, oncology, biomarkers, and metabolism disorders. By partnering with healthcare providers, ObjectiveHealth aims to expand research opportunities and improve patient care within these specialties.

Industry Significance

ObjectiveHealth plays a pivotal role in bridging the gap between clinical research and patient care. Its innovative approach addresses common challenges in clinical trials, such as patient recruitment and retention, by integrating research into existing healthcare practices. This model not only enhances the efficiency of clinical trials but also provides patients with greater access to cutting-edge treatments.

Key Strategic Focus

Core Objectives

• Integration of Clinical Research: Embed clinical trials into physician practices and community health centers to provide patients with access to innovative treatments within their trusted care environments.

• Enhancement of Patient Outcomes: Utilize clinical research to improve disease management and support patients in achieving better health outcomes.

• Expansion of Research Opportunities: Broaden the scope of clinical trials across various therapeutic areas to address a wide range of health conditions.

Specific Areas of Specialization

• Therapeutic Areas: Conduct clinical trials in gastroenterology, dermatology, urology, oncology, biomarkers, and metabolism disorders.

• Patient Recruitment and Retention: Implement strategies to identify, prequalify, and retain patients for clinical trials, thereby enhancing trial efficiency and outcomes.

Key Technologies Utilized

• AI-Driven Platforms: Develop and deploy proprietary AI technologies, such as ObjectiveScreen, to streamline patient identification and recruitment processes.

• Electronic Health Record (EHR) Integration: Integrate with EHR systems to access patient data, facilitating efficient patient recruitment and management.

Primary Markets or Conditions Targeted

• Healthcare Providers: Partner with physicians and healthcare organizations to integrate clinical research into their practices.

• Pharmaceutical Sponsors: Collaborate with pharmaceutical companies and contract research organizations (CROs) to conduct clinical trials.

• Patients: Offer patients access to clinical trials, providing them with opportunities to participate in research studies within their communities.

Financials and Funding

Funding History

ObjectiveHealth has secured strategic growth investments to support its expansion and technological advancements.

• Vitruvian Partners Investment: In January 2024, ObjectiveHealth received a strategic growth investment from Vitruvian Partners, a global growth-focused investment firm. The amount of the deal was not disclosed.

Total Funds Raised

The company has raised a total of $21.42 million in funding.

Notable Investors

• Vitruvian Partners: A global growth-focused investment firm that invested in ObjectiveHealth in January 2024.

• Frist Cressey Ventures: An investment firm that has supported ObjectiveHealth's growth initiatives.

• BIP Ventures: Another strategic investor contributing to ObjectiveHealth's expansion.

Intended Utilization of Capital

The funds are intended to expand ObjectiveHealth's operations, enhance its technological capabilities, and support the growth of its clinical research network.

Pipeline Development

Key Pipeline Candidates

ObjectiveHealth's pipeline includes clinical trials across various therapeutic areas, focusing on conditions such as:

• Gastroenterology: Including studies on fatty liver disease and metabolic syndrome.

• Dermatology: Focusing on conditions like acne, atopic dermatitis, rosacea, and psoriasis.

• Urology: Addressing disorders such as benign prostatic hypertrophy, kidney stone disease, urinary tract infections, and overactive bladder.

• Oncology: Conducting interventional cancer trials and research on predictive biomarkers in precision medicine diagnostics.

Stages of Clinical Trials or Product Development

ObjectiveHealth is involved in various stages of clinical trials, from early-phase studies to interventional trials, across multiple therapeutic areas.

Target Conditions

The company targets a wide range of conditions, including chronic diseases, dermatological disorders, urological diseases, and cancers.

Relevant Timelines for Anticipated Milestones

Specific timelines for milestones vary by study and therapeutic area. ObjectiveHealth continues to expand its research portfolio and anticipates ongoing growth in its clinical trial offerings.

Technological Platform and Innovation

Proprietary Technologies

• ObjectiveScreen: An AI-powered feasibility and recruitment platform that optimizes clinical trial performance by enhancing patient identification, prequalification, and retention.

• ObjectiveView: A technology portal providing clinical trial sponsors with transparency into study and site-specific quality performance metrics.

Significant Scientific Methods

• AI and Machine Learning Algorithms: Utilize advanced algorithms to analyze electronic health record data, facilitating efficient patient recruitment and management.

• EHR Integration: Seamlessly integrate with EHR systems to access and analyze patient data, improving trial efficiency and patient outcomes.

Leadership Team

Key Executive Profiles

• Steve Clemons: Chief Executive Officer (CEO)

• Professional Background: A veteran clinical research executive with experience in co-founding multiple research entities, including VitaLink Research. Prior to joining ObjectiveHealth, he was COO of Rymedi, a founder-based technology startup.

• Key Contributions: Guided ObjectiveHealth through a period of significant growth and expansion, leveraging his expertise to enhance the company's strategic direction.

• Colleen Hoke: Co-founder and Chief Executive Officer (CEO)

• Professional Background: Co-founded ObjectiveHealth and has been instrumental in its growth and development.

• Key Contributions: Led the company through its rebranding from ObjectiveGI to ObjectiveHealth, reflecting a broader focus on various therapeutic areas.

• Don Lazas, MD: Co-founder and Chief Medical Officer (CMO)

• Professional Background: A gastroenterologist with extensive experience in clinical research.

• Key Contributions: Oversees the clinical aspects of ObjectiveHealth's operations, ensuring the integration of research into patient care.

Leadership Changes

Recent Significant Changes or Appointments

• Steve Clemons as CEO: In January 2025, Steve Clemons joined ObjectiveHealth as CEO, bringing extensive experience in clinical research and healthcare leadership.

Competitor Profile

Market Insights and Dynamics

The clinical research industry is experiencing significant growth, driven by the increasing complexity of clinical trials and the need for efficient patient recruitment and retention strategies. Companies like ObjectiveHealth are well-positioned to address these challenges by integrating research into existing healthcare practices.

Competitor Analysis

ObjectiveHealth operates in a competitive landscape that includes other integrated research providers and contract research organizations (CROs). Key competitors may offer similar services but may not have the same level of integration with healthcare providers or the proprietary technology that sets ObjectiveHealth apart.

Strategic Collaborations and Partnerships

Significant Collaborations

• QualDerm Partners: Expanded partnership to integrate clinical research into 158 skin care and aesthetics practices across 17 states, serving over 1.5 million patients annually.

• Urology of St. Louis: Established a joint clinical research center, Specialty Clinical Research of St. Louis, to provide access to advanced diagnostic tools and treatments for urologic diseases.

Operational Insights

Strategic Considerations

ObjectiveHealth's integrated point-of-care clinical research model addresses critical industry challenges regarding patient recruitment and retention. The company's proprietary technologies and partnerships with healthcare providers enable it to efficiently embed clinical trials into routine patient care, enhancing trial execution and patient access to novel therapies.